Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Connect Biopharma Holdings Ltd ADR (NQ: CNTB )

0.7165 -0.0409 (-5.40%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 37,243
Open 0.7572
Bid (Size) 0.7165 (10)
Ask (Size) 0.7400 (11)
Prev. Close 0.7574
Today's Range 0.7006 - 0.7573
52wk Range 0.5573 - 5.990
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Connect Biopharma To Present at Upcoming Investor and Scientific Conferences
From Connect Biopharma Holdings Limited
Via Globe NewsWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another dive into the biggest pre-market stock movers as we check out the latest stock news for Thursday morning! 
Via InvestorPlace

Performance

YTD
-87.90%
-87.90%
1 Month
-11.54%
-11.54%
3 Month
-44.46%
-44.46%
6 Month
-9.34%
-9.34%
1 Year
-83.93%
-83.93%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Connect Biopharma Lead Candidate Aces Pivotal Atopic Dermatitis Trial In Chinese Patients
Via Benzinga
Connect Biopharma's Candidate For Skin Disease-Associated Itch Shows Encouraging Safety Profile
Via Benzinga
Connect Biopharma Sees CBP-201 Topline Data From China Atopic Dermatitis Trial This Year
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Week In Review: AIM Vaccine Stages $20 Million IPO On Hong Kong Exchange
Via Talk Markets
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
CORRECTING and REPLACING -- Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in China
From Connect Biopharma Holdings Limited
Via Globe NewsWire
Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in China
From Connect Biopharma Holdings Limited
Via Globe NewsWire
Connect Biopharma to Host a Conference Call Tuesday, October 4 to Discuss Topline Results for the Pivotal Trial in China of Lead Candidate, CBP-201, in Patients with Moderate-to-Severe Atopic Dermatitis
From Connect Biopharma Holdings Limited
Via Globe NewsWire
Earnings Scheduled For September 13, 2022
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
Via Benzinga
Week In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology Investments
Via Talk Markets
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
Via Benzinga
Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Via Benzinga
Aspen Aerogels And 28 Stocks Moving Premarket
Via Benzinga
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.